Pharmacy hosting fears that the overall reform is unfavorable?

In March of this year, China Resources Pharmaceutical, Guangzhou Pharmaceutical Baiyunshan and the three giants of Sinopharm Group, after the United States and the United States through the "pharmacy trusteeship" in the capital market after frequent enclosures, has for the "pharmacy trusteeship" voice. In the context of policy-making policies that have not yet introduced supporting policies, pharmaceutical companies have focused on pharmacy trusteeship, which means that it is worth considering.

According to Yao Hongwen, spokesperson of the State Health and Family Planning Commission, said earlier this year: “We believe that the phenomenon of pharmacies being peeled off from clinics in some areas will play a role in cutting off the direct interest relationship between medical personnel and medicines.” Presenting does not completely oppose the idea of ​​pharmacy trusteeship.

Different from the attitude of the ministry, Liao Xinbo, deputy director of the Guangdong Provincial Health and Development Commission, bluntly stated at the 2014 drug fair that under the current policy environment, pharmacy trusteeship is only due to profitability, and its behavior cannot be protected by law. More importantly, it may be. It is a devastating blow to pharmacy services.

Wang Ruwei, a director and executive vice president of Zhejiang Kangenbei Pharmaceutical Co., Ltd., wrote a prescription for this, pointing out that only by cutting off the hidden benefits of medicines and doctors, can the root cause break the high drug prices and promote the development of new medical reforms.

Pharmacy Hosting Lack of Policy Guidance

At present, none of the relevant ministries and commissions, including the State Health and Family Planning Commission, the Ministry of Commerce, and the Food and Drug Administration, have issued specific guidelines or other documents for the pharmacy custody. However, this does not prevent the major pharmaceutical companies from having high enthusiasm for pharmacy trusteeship.

On March 17, the annual report of Guangyao Baiyunshan showed that the company's trading business continued to dig deeper into drug sales channels and networks, actively explored new types of business, and vigorously launched pharmacy custody services. The pharmaceutical company has signed an extension cooperation agreement with a number of hospitals such as the Guangdong Provincial Second People's Hospital, Meizhou Taipu People's Hospital and other hospitals. Cailin Pharmaceutical has acquired the communities of Liwan District, Haizhu District, Baiyun District and Huangpu District of Guangzhou City. Hospitals and some taiwan hospital pharmacies are fully managed. Guangpiao said in a high-profile manner that in 2014, the Group made full use of various opportunities and resources to fully develop the pharmacy custody business and build a new business situation.

According to the “Economic Information Daily” report, a person close to the chairman of GP Group stated that GP hopes to find a new profit growth point through pharmacy custody business. “Moreover, China Resources Medicine and Sinopharm Group have all snagged in Guangdong, and Guangpeng certainly can't lag behind.” On March 19, Sinopharm Group also stated in its annual report that it will use its subsidiary Sinopharm's strengths to expand its resources. Beijing hospital pharmacy hosting business.

Guoxin Securities research report shows that the zero addition of drugs in the future is irresistible, the pharmacy will become a cost center, and the hospital will have the incentive to outsource it. The hosting company is not a purely commercial enterprise, but has a very large pharmaceutical industry and can enjoy the high profit rate of self-produced drugs sold exclusively to hospitals. “We think the net interest rate for pharmacy custody business is about 5%~10%, which will affect future industry development.”

Liao Xinbo stated that not only is there a lack of policy guidance, but also that it is difficult for the pharmaceutical companies and hospitals that have already implemented pharmacy custody to seek legal protection.

Specifically, the pharmacy trusteeship is a paid operation and management, and the willingness to establish a contractual relationship with the drug business enterprise entrusted with the contract by signing a custody contract clarifies the rights and obligations of both parties. However, in terms of the connotation of pharmacy trusteeship, the concepts of trust and trust in hospitals and trustees are unclear, and there is no legal support.

Create a blow to pharmacy services

In addition to the difficulties in getting involved in the pharmacy escrow relationship, it is difficult to consolidate the interests of the pharmacy trustee. From the perspective of the State Council's plan to advance the development of new medical reforms, pharmacy trusteeship is currently unfavorable to the overall reform.

According to Liao Xinbo, after the pharmacy is escrowed, the compensation for hospital finances is a problem. At present, more than one hospital in China cancels 15% of drug addiction on trial basis, and the way of financial compensation is that the government will pay 20%, and the remaining 80% will be paid by medical insurance. "In fact, the current 20% of the government has not honoured this, and it has also made the elimination of drug additions an obstacle."

He disclosed that taking Guangdong Province as an example, the province canceled drug additions, and the government is not happy to receive 10% of financial compensation. Imagine being a big, economically developed province of medicine, facing the separation of medicine and investing in financial compensation, it is all twists and turns. What's more, other economic development conditions are not as good as those in Guangdong.

“The pharmacy trusteeship is not a matter of medicine and medicine. It must be a multi-sectoral synergy. In fact, the pharmacy of the hospital is not a simple trade. It also has many pharmacy work, special drug management, and reports of adverse drug reactions. There are no definite answers to how these are conducted after the trusteeship has been conducted.” Liao Xinbo bluntly stated that pharmacy trusteeship only pays attention to the management of drugs and neglects rational drug use and safe drug use. Therefore, the Department of Pharmacy of the hospital believes that this Work is devastating.

Retrospective medical reform in the past, the change from medicine to a breakthrough is not an integrated reform. If medical reform is regarded as a comprehensive reform, there may be more problems. With the implementation of the hospital's zero spread, how to solve the doctor's labor costs has become a strange phenomenon - to pay for medical care, excessive medical behavior has become another caliber.

At the same time, the only low prices currently faced are the bidding policies adopted, which led to the disappearance of low-priced drugs and excessive drug use. This not only manifests itself in aggravating the burden on patients, but also brings about potential risks or misuse. In addition, most of the drug species entering the base drug list have not been evaluated by pharmacoeconomics, and the scientific nature and basis have yet to be further verified.

After the pharmacy is escrowed, a new chain of interest in drug purchases and sales may be formed. The trustee and the doctor may cooperate with each other, and it may be easier to obtain a rebate by opening a “large prescription” and high-priced drugs. Wang Ruwei stated that in the context of the current policy, including pharmacy trusteeship, the problem of high drug prices cannot be solved, and if one wants to crack the root cause, it is necessary to cut off the sale of drugs and the hidden benefits of doctors and follow up with relevant details as soon as possible. Supervision is in place to ensure the independence of pharmacies and hospitals.